COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Cannabis Science, Inc. (OTCBB: CBIS), a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to announce that Robert Kane, formerly of Stifel Nicolaus (NYSE:SF), has been retained by Cannabis Science in the capacity of Investor Relations Management to increase Company exposure, access to capital, and ultimately increase shareholder value.
